Posted by Michael Wonder on 31 May 2022
New Zealand Pharmaceutical Schedule - 1 June 2022
1 June 2022 - The June 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.
There are a few new/revised listings of note this month:
- Eftrenonacog alfa (Alprolix) - new strength
- Eplerenone (Inspra) - restriction change
- Palivizumab (Synagis) - new medicine
We have coded palivuzumab as a new medicine even though it was first registered by Medsafe in 1999.
Other than medicines for COVID-19, PHARMAC has not listed a genuine new medicine (i.e. medicine first registered by Nedsafe in the say the past 10 years) for the first six months of 2022.
